Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher A Ross

Showing results (121-130 of 244) with videos related to

Pageof 25
Sort By:
Neuroreport|March 27, 2003
Inducible PC12 cell model of Huntington's disease shows toxicity and decreased histone acetylationShuichi Igarashi, Hokuto Morita, Kyla M Bennett, et al.
ACS Chemical Neuroscience|September 15, 2022
Neuroprotective Effects of σ<sub>2</sub>R/TMEM97 Receptor Modulators in the Neuronal Model of Huntington's DiseaseJing Jin, Nicolas Arbez, James J Sahn, et al.
American Journal of Medical Genetics. Part A|May 13, 2005
FXTAS, SCA10, and SCA17 in American patients with movement disordersAna I Seixas, Martin H Maurer, Mark Lin, et al.
Journal of Huntington'S Disease|July 27, 2014
Regional atrophy associated with cognitive and motor function in prodromal Huntington diseaseElizabeth H Aylward, Deborah L Harrington, James A Mills, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|May 14, 2010
"Frontal" behaviors before the diagnosis of Huntington's disease and their relationship to markers of disease progression: evidence of early lack of awarenessKevin Duff, Jane S Paulsen, Leigh J Beglinger, et al.
Annals of Neurology|February 28, 2012
Loss of junctophilin-3 contributes to Huntington disease-like 2 pathogenesisAna I Seixas, Susan E Holmes, Hiroshi Takeshima, et al.
Cell Cycle (Georgetown, Tex.)|December 25, 2007
N-terminal proteolysis of full-length mutant huntingtin in an inducible PC12 cell model of Huntington's diseaseTamara Ratovitski, Masayuki Nakamura, James D'Ambola, et al.
Brain Research|June 30, 2009
ATF3 plays a protective role against toxicity by N-terminal fragment of mutant huntingtin in stable PC12 cell lineYideng Liang, Haibing Jiang, Tamara Ratovitski, et al.
Human Molecular Genetics|December 10, 2021
Interaction of huntingtin with PRMTs and its subsequent arginine methylation affects HTT solubility, phase transition behavior and neuronal toxicityTamara Ratovitski, Mali Jiang, Robert N O'Meally, et al.
Brain Research Bulletin|April 14, 2010
Striatal and white matter predictors of estimated diagnosis for Huntington diseaseJane S Paulsen, Peggy C Nopoulos, Elizabeth Aylward, et al.
Pageof 25

Showing results (121-130 of 244) with videos related to

Sort By:
Pageof 25
Neuroreport|March 27, 2003
Inducible PC12 cell model of Huntington's disease shows toxicity and decreased histone acetylationShuichi Igarashi, Hokuto Morita, Kyla M Bennett, et al.
ACS Chemical Neuroscience|September 15, 2022
Neuroprotective Effects of σ<sub>2</sub>R/TMEM97 Receptor Modulators in the Neuronal Model of Huntington's DiseaseJing Jin, Nicolas Arbez, James J Sahn, et al.
American Journal of Medical Genetics. Part A|May 13, 2005
FXTAS, SCA10, and SCA17 in American patients with movement disordersAna I Seixas, Martin H Maurer, Mark Lin, et al.
Journal of Huntington'S Disease|July 27, 2014
Regional atrophy associated with cognitive and motor function in prodromal Huntington diseaseElizabeth H Aylward, Deborah L Harrington, James A Mills, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|May 14, 2010
"Frontal" behaviors before the diagnosis of Huntington's disease and their relationship to markers of disease progression: evidence of early lack of awarenessKevin Duff, Jane S Paulsen, Leigh J Beglinger, et al.
Annals of Neurology|February 28, 2012
Loss of junctophilin-3 contributes to Huntington disease-like 2 pathogenesisAna I Seixas, Susan E Holmes, Hiroshi Takeshima, et al.
Cell Cycle (Georgetown, Tex.)|December 25, 2007
N-terminal proteolysis of full-length mutant huntingtin in an inducible PC12 cell model of Huntington's diseaseTamara Ratovitski, Masayuki Nakamura, James D'Ambola, et al.
Brain Research|June 30, 2009
ATF3 plays a protective role against toxicity by N-terminal fragment of mutant huntingtin in stable PC12 cell lineYideng Liang, Haibing Jiang, Tamara Ratovitski, et al.
Human Molecular Genetics|December 10, 2021
Interaction of huntingtin with PRMTs and its subsequent arginine methylation affects HTT solubility, phase transition behavior and neuronal toxicityTamara Ratovitski, Mali Jiang, Robert N O'Meally, et al.
Brain Research Bulletin|April 14, 2010
Striatal and white matter predictors of estimated diagnosis for Huntington diseaseJane S Paulsen, Peggy C Nopoulos, Elizabeth Aylward, et al.
Pageof 25